search
Back to results

Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait in Patients With Cerebellar Ataxia Gene

Primary Purpose

Cerebellar Ataxia

Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait
walking track GAITRite,manual dynamometer, and treadmill
Sponsored by
Centre Hospitalier Universitaire de Nice
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cerebellar Ataxia

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient aged 18 to 60;
  • Patient with cerebellar syndrome genetically determined or evidence of inheritance;
  • Patient walking more than 50 meters independently, with or without technical assistance;
  • Patient likely to be followed regularly for at least one year;
  • Patient has given written informed consent;
  • Patient affiliated to Social Security.

Exclusion Criteria:

  • Patient with any other injuries not attributable to the pathology and can influence the running tests according to physician judgment;
  • Patient with any disease or condition incompatible to the success of the study according to the doctor's judgment;
  • Patient not strolling or sauntering only with a third person to help;
  • Major person under guardianship;
  • People hospitalized without his consent and not protected by law;
  • Nobody deprived of liberty;
  • Patients speakers.

Sites / Locations

  • CHU de NiceRecruiting

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

cerebellar ataxia

Arm Description

Evaluation ataxia according SARAs; measuring the quality of life through SF36 Questionnaire; quantifying the severity of fatigue perceived by FSS questionnaire quantifying the severity of physical tiredness by VAS before and after physical activity; quantified analysis of walking on walking track GAITRite® (with score calculation FAP and GVI) before and after physical activity; physical activity like walking on a treadmill (with measurement of maximal voluntary quadriceps by manual dynamometer before and after physical activity to ensure the induction of fatigue). Patients will be provided with a portable device for analyzing gas exchange FitMateMED® (COSMED, Rome, Italy) during walking analyzes GAITRite®

Outcomes

Primary Outcome Measures

Pre physical activity scores (Gilette Gait Index (GVI)) to pre exercise walking
The main objective is to investigate the relationship between changes in energy expenditure and changes in instability when walking at one year in patients with cerebellar ataxia gene.
Oxygen consumption to pre exercise walking
The main objective is to investigate the relationship between changes in energy expenditure and changes in instability when walking at one year in patients with cerebellar ataxia gene.
Pre physical activity scores (Functional Ambulation Performance Score (FAPS)) to pre exercise walking
The main objective is to investigate the relationship between changes in energy expenditure and changes in instability when walking at one year in patients with cerebellar ataxia gene.

Secondary Outcome Measures

Functional Systems Scores (FSS) score
Study, after one year of development, the relationship between fatigue, instability, energy consumption, the number of falls, the severity of ataxia and quality of life.
Visual Analog Scale (VAS) tiredness
Study, after one year of development, the relationship between fatigue, instability, energy consumption, the number of falls, the severity of ataxia and quality of life.

Full Information

First Posted
July 22, 2016
Last Updated
December 14, 2017
Sponsor
Centre Hospitalier Universitaire de Nice
search

1. Study Identification

Unique Protocol Identification Number
NCT02903290
Brief Title
Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait in Patients With Cerebellar Ataxia Gene
Official Title
Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait in Patients With Cerebellar Ataxia Gene
Study Type
Interventional

2. Study Status

Record Verification Date
December 2017
Overall Recruitment Status
Unknown status
Study Start Date
January 2017 (Actual)
Primary Completion Date
January 2017 (Actual)
Study Completion Date
December 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire de Nice

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Genetic cerebellar ataxias involves progressive degeneration of the cerebellum. Their overall prevalence is estimated at 2-4 cases per 100 000 people. These diseases are manifested by a static and kinetic cerebellar syndrome characterized by impaired balance, coordination, and an ataxic gait. To date, no therapy is available for patients and physical therapy is essential and recommended. The evolution of the pathology causes a degradation of walking, increased instability and risk of falling. In one year, between 74% and 93% of patients reported having fallen at least once. Falls prevention by understanding the mechanisms affecting stability is a major issue in the management of these patients physiotherapy. The analysis of the literature, we assume that there exists a trio "fatigue - instability - energy expenditure" in which the three parameters would influence each other. To date, we do not have data to characterize these interrelationships and their evolution over time. STUDY OBJECTIVES: The main objective is to study the relationship between changes in energy expenditure and changes in instability when walking at one year in patients with cerebellar ataxia gene. The secondary objectives are to study, after one year of development, the relationship between fatigue, instability, energy consumption, the number of falls, the severity of ataxia and quality of life. CONDUCT OF THE STUDY: This is a pilot, multicenter, interventional. The projected duration of patient recruitment will be 12 months and the total number of patients will be included in 15. The duration of participation in this study is 12 months for each patient. The anticipated duration of the study is 30 months. Development of the study: Patients included will perform two sets (S1 and S2) tests a year apart including the evaluation of ataxia according Scale for the assessment and rating of ataxia (SARA); measuring the quality of life through SF36 (The Short Form (36)) Questionnaire; quantifying the severity of fatigue perceived by FSS questionnaire quantifying the severity of physical tiredness by VAS before and after physical activity; quantified analysis of walking on walking track GAITRite® (with score calculation FAP and GVI) before and after physical activity; physical activity like walking on a treadmill (with measurement of maximal voluntary quadriceps by manual dynamometer before and after physical activity to ensure the induction of fatigue). Patients will be provided with a portable device for analyzing gas exchange FitMateMED® (COSMED, Rome, Italy) during walking analyzes GAITRite®.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cerebellar Ataxia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
15 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
cerebellar ataxia
Arm Type
Other
Arm Description
Evaluation ataxia according SARAs; measuring the quality of life through SF36 Questionnaire; quantifying the severity of fatigue perceived by FSS questionnaire quantifying the severity of physical tiredness by VAS before and after physical activity; quantified analysis of walking on walking track GAITRite® (with score calculation FAP and GVI) before and after physical activity; physical activity like walking on a treadmill (with measurement of maximal voluntary quadriceps by manual dynamometer before and after physical activity to ensure the induction of fatigue). Patients will be provided with a portable device for analyzing gas exchange FitMateMED® (COSMED, Rome, Italy) during walking analyzes GAITRite®
Intervention Type
Other
Intervention Name(s)
Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait
Intervention Type
Other
Intervention Name(s)
walking track GAITRite,manual dynamometer, and treadmill
Primary Outcome Measure Information:
Title
Pre physical activity scores (Gilette Gait Index (GVI)) to pre exercise walking
Description
The main objective is to investigate the relationship between changes in energy expenditure and changes in instability when walking at one year in patients with cerebellar ataxia gene.
Time Frame
At one year
Title
Oxygen consumption to pre exercise walking
Description
The main objective is to investigate the relationship between changes in energy expenditure and changes in instability when walking at one year in patients with cerebellar ataxia gene.
Time Frame
At one year
Title
Pre physical activity scores (Functional Ambulation Performance Score (FAPS)) to pre exercise walking
Description
The main objective is to investigate the relationship between changes in energy expenditure and changes in instability when walking at one year in patients with cerebellar ataxia gene.
Time Frame
At one year
Secondary Outcome Measure Information:
Title
Functional Systems Scores (FSS) score
Description
Study, after one year of development, the relationship between fatigue, instability, energy consumption, the number of falls, the severity of ataxia and quality of life.
Time Frame
At one year
Title
Visual Analog Scale (VAS) tiredness
Description
Study, after one year of development, the relationship between fatigue, instability, energy consumption, the number of falls, the severity of ataxia and quality of life.
Time Frame
At one year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient aged 18 to 60; Patient with cerebellar syndrome genetically determined or evidence of inheritance; Patient walking more than 50 meters independently, with or without technical assistance; Patient likely to be followed regularly for at least one year; Patient has given written informed consent; Patient affiliated to Social Security. Exclusion Criteria: Patient with any other injuries not attributable to the pathology and can influence the running tests according to physician judgment; Patient with any disease or condition incompatible to the success of the study according to the doctor's judgment; Patient not strolling or sauntering only with a third person to help; Major person under guardianship; People hospitalized without his consent and not protected by law; Nobody deprived of liberty; Patients speakers.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
GARCIA JEREMY
Email
garcia.j@chu-nice.fr
First Name & Middle Initial & Last Name or Official Title & Degree
SACCONI Sabrina
Email
sacconi.s@chu-nice.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
SACCONI Sabrina
Organizational Affiliation
Centre Hospitalier Universitaire de Nice
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU de Nice
City
Nice
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
GARCIA JEREMY
Email
garcia.j@chu-nice.fr

12. IPD Sharing Statement

Learn more about this trial

Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait in Patients With Cerebellar Ataxia Gene

We'll reach out to this number within 24 hrs